70 results
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
7 May 20
MeiraGTx Reports First Quarter 2020 Financial Results
4:38pm
million, which was partially offset by increases in costs related to the manufacture of material for clinical trials and costs related to clinical … costs and rent and facilities costs, which was partially offset by a decrease in legal and consulting fees.
Foreign currency loss was $0.8 million
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
11 May 21
MeiraGTx Reports First Quarter 2021 Financial and Operational Results
8:13am
2018 becoming fully vested in June 2020. These decreases were partially offset by increases of $0.6 million in insurance costs, $0.6 million in rent … and a decrease of $2.3 million in research funding provided under our collaboration agreement with Janssen, which was partially offset by decreases of $2.2
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
7 Aug 19
MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update
8:22am
ended June 30, 2018.
The decrease of $3.9 million was primarily due to decreases in payroll and share-based compensation, which was partially offset … was partially offset by $2.5 million in research funding provided by our license and collaboration agreements with Janssen, and other research
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
11 Aug 21
MeiraGTx Reports Second Quarter 2021 Financial and Operational Results
8:11am
2018 becoming fully vested in June 2020, legal and accounting fees and other office related costs. These decreases were partially offset by increases … collaboration agreement with Janssen. The decrease was partially offset by increases in costs related to our pre-clinical research and clinical trials, costs
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
8 Aug 18
MeiraGTx Reports Second Quarter 2018 Financial Results and Provides Corporate Update
8:17am
attributable to increases in payroll and stock-based compensation, consultant and operational costs, which was partially offset by a decrease in rent … facility for production and stock-based compensation, which was partially offset by a decrease in clinical trial material costs.
Foreign currency
8-K
EX-99.1
3u75jpnxpp6
11 Mar 20
MeiraGTx Reports Full Year 2019 Financial Results
5:07pm
8-K
EX-99.1
rgms1znn0pn
14 May 19
MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update
9:11pm
8-K
EX-99.1
m0f6rix
8 Nov 18
MeiraGTx Reports Third Quarter 2018 Financial Results and Provides Corporate Update
8:35am
8-K
EX-99.1
j2xq ar7t3tj
12 May 22
MeiraGTx Reports First Quarter 2022 Financial and Operational Results
8:11am
8-K
EX-99.1
fpe1wocgti8lh 5nf90
10 Nov 21
MeiraGTx Reports Third Quarter 2021 Financial and Operational Results
8:18am
8-K
EX-99.1
2vg8xw8u mw38
6 Aug 20
MeiraGTx Reports Second Quarter 2020 Financial Results
8:15am
8-K
EX-99.1
bd0 ur9tv9ndfyy2e06
11 Aug 22
MeiraGTx Reports Second Quarter 2022 Financial and Operational Results
8:33am
8-K
EX-99.1
vfxb0 fzy1
10 Mar 22
MeiraGTx Reports Fourth Quarter and Full Year 2021 Financial and Operational Results
8:15am
8-K
EX-99.1
h8kczlqu
10 Nov 22
Entry into a Material Definitive Agreement
8:07am
8-K
EX-99.1
ytli05rfzd6
11 May 23
MeiraGTx Reports First Quarter 2023 Financial and Operational Results
8:12am
8-K
EX-99.1
f4tiac90
10 Aug 23
MeiraGTx Reports Second Quarter 2023 Financial and Operational Results
8:13am
8-K
EX-99.1
gbr2 2wp0zi
11 Mar 21
MeiraGTx Reports Fourth Quarter and Full Year 2020 Financial and Operational Results
8:14am
8-K
EX-99.1
4puzalbmc1hp r4
14 Nov 23
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
12:00am
DEFA14A
6lmaopksiujs 7hpiy7
28 Apr 21
Additional proxy soliciting materials
7:42am
DEFA14A
j8mizogix2oypv64jv
26 May 20
Additional proxy soliciting materials
8:36am